Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to alter the gastric acid pocket position in GERD
NL-OMON33309Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of azithromycin in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Number of reflux episodes and Distance of acid pocket to crural diaphragm and lower esophageal sphincter. Planned start Sep 2009; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NL-OMON33309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33309.